Self-Expanding Stents Market Report 2025

This Self-Expanding Stents market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The self-expanding stents market size has grown strongly in recent years. It will grow from $3.31 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to increased awareness, growth in aging population, expansion of indications for stent usage beyond coronary arteries, growth in disposable income levels, and increased adoption of minimally invasive procedures.

The self-expanding stents market size is expected to see strong growth in the next few years. It will grow to $4.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular diseases, expansion of healthcare infrastructure, expansion of telemedicine services for remote consultation, growing incidence of peripheral arterial disease, and increase in the prevalence of chronic diseases. Major trends in the forecast period include technological advancements, bioresorbable stents, drug-eluting stents, minimally invasive procedures, and integration of artificial intelligence.

The increasing incidence of cardiovascular diseases is expected to drive the growth of the self-expanding stents market. Cardiovascular diseases are conditions that affect the heart and blood vessels, and their rising prevalence is largely attributed to factors such as obesity, an aging population, and genetic predispositions. Self-expanding stents are effective in treating cardiovascular disorders, offering minimally invasive therapeutic options for both urgent and long-term patient needs. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research organization, revealed that approximately 7.6 million people in the UK are affected by heart and circulatory diseases. This includes around 4 million men and 3.6 million women living with these conditions. Cardiovascular diseases account for about 27% of all deaths in the UK, leading to over 170,000 deaths annually - roughly 480 deaths per day, or one death every three minutes. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the self-expanding stents market.

Key players in the self-expanding stents sector are directing their focus towards introducing innovative solutions such as the tracheal stent system, aimed at reducing the requirement for open surgery and enhancing market competitiveness. A tracheal stent system serves as a medical device to support and uphold tracheal patency, commonly utilized in cases of tracheal stenosis or collapse. For example, in February 2022, Micro-Tech Endoscopy Inc., a US-based medical technology firm, unveiled a tracheobronchial nitinol y-stent. This flexible, self-expanding stent, crafted from a nitinol alloy, features a low-profile delivery mechanism, silicone coating to prevent tumor ingrowth, and repositionable sutures for adjustment or removal, providing relief to individuals with tracheobronchial strictures by widening the airway and improving airflow.

In January 2024, Olympus Corporation, a Japan-based technology conglomerate, completed the acquisition of Taewoong Medical Co., Ltd. The undisclosed transaction was aimed at bolstering Olympus Corporation's gastrointestinal (GI) endotherapy product lineup and fortifying its capabilities in offering comprehensive solutions for GI treatments. Taewoong Medical Co. Ltd., based in South Korea, specializes in manufacturing self-expanding metallic stents (SEMS) for various gastrointestinal applications.

Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson and Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE & Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH.

North America was the largest region in the self-expanding stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the self-expanding stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Self-expanding stents are medical devices engineered to open and uphold the patency (openness) of narrowed or obstructed blood vessels or tubular structures within the body. Constructed from flexible materials, often metal alloys such as nitinol, these stents possess the characteristic of self-expansion upon deployment in the body. The objective of self-expanding stents is to address various medical conditions characterized by the narrowing or occlusion of blood vessels or other tubular structures.

The primary types of self-expanding stents include gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents, and others. Gastrointestinal self-expanding stents are medical devices utilized for treating narrowings or blockages in the digestive tract, as they expand and provide support to the affected area. They find applications in various settings such as fem-pop artery stents, iliac artery stents, carotid artery stents, biliary stents, and others. End users of these stents include hospitals, ambulatory surgical centers, and other healthcare facilities.

The self-expanding stents research report is one of a series of new reports that provides self-expanding stents market statistics, including the self-expanding stents industry's global market size, regional shares, competitors with a self-expanding stents market share, detailed self-expanding stents market segments, market trends and opportunities, and any further data you may need to thrive in the self-expanding stents industry. This self-expanding stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The self-expanding stents market consists of sales of coronary self-expanding stents, peripheral self-expanding stents, and biliary self-expanding stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.